New Delhi, 12 May 2026: On the occasion of National Technology Day 2026, a grand display of India’s scientific capability was seen. 14 scientific ministries and departments of the country came together on one platform in a special program organized at the BRIC National Institute of Immunology, New Delhi. In this program, many medical technologies showing India’s self-reliance were presented by ICMR (Indian Council of Medical Research).
ICMR had showcased 6 major technologies developed in the fields of biopharma, health and green chemicals. Which includes Covaxin, Covid Kavach ELISA kit, CRISPR based TB testing system, Nipah test kit, dengue testing kit and biolarvicide for mosquito control. The biggest achievement of this program was that ICMR has handed over three of its important indigenous medical technologies to the private industry through license for commercial production.
ICMR has handed over low-cost ELISA technology for prostate cancer diagnosis to Krishgen Labs. Similarly, ‘Point-of-Care’ diagnostic technology for rapid diagnosis of blood clotting disorders has been transferred to Meril Life Sciences. RT-PCR technology that can simultaneously test dengue, chikungunya and Zika virus has been handed over to Vanguard Life Sciences.
According to ICMR, the main objective of this step is to accelerate the production of indigenous medical equipment in the country and to make health facilities affordable for the general public. By directly linking medical research with industry, India is now moving towards reducing foreign dependence in the healthcare sector. This Sci-Tech program has proved that when the government, scientific institutions and industrialists come together, the goal of ‘Developed India’ seems closer. This scientific strength of India will increase the prestige of the country at the global level in the future.
Comments are closed.